| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Jetblack Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0027 |
| 52 Week High | US$0.0067 |
| 52 Week Low | US$0.0015 |
| Beta | 0 |
| 1 Month Change | -12.90% |
| 3 Month Change | -28.95% |
| 1 Year Change | 25.58% |
| 3 Year Change | -90.36% |
| 5 Year Change | -99.60% |
| Change since IPO | 192.21% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| JTBK | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -34.1% | -0.01% | 2.0% |
| 1Y | 25.6% | 9.5% | 22.3% |
Return vs Industry: JTBK exceeded the US Pharmaceuticals industry which returned 9.5% over the past year.
Return vs Market: JTBK exceeded the US Market which returned 22.3% over the past year.
Price Volatility
| JTBK volatility | |
|---|---|
| JTBK Average Weekly Movement | 45.0% |
| Pharmaceuticals Industry Average Movement | 9.7% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: JTBK's share price has been volatile over the past 3 months.
Volatility Over Time: JTBK's weekly volatility has decreased from 57% to 45% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | n/a | Dan Goldin | www.jetblackcorp.com |
Jetblack Corp. does not have significant operations. It is seeking strategic minority acquisitions and investments into high-growth sectors to increase assets and shareholder value. The company intends to make investments in digital assets.
Jetblack Corp. Fundamentals Summary
| JTBK fundamental statistics | |
|---|---|
| Market cap | US$2.52m |
| Earnings (TTM) | -US$311.16k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs JTBK overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| JTBK income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$311.17k |
| Earnings | -US$311.16k |
Last Reported Earnings
Mar 31, 2019
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did JTBK perform over the long term?
See historical performance and comparison